Is risk-reducing removal of the ovaries and tubes needed before menopause management after cancer?

Risk-reducing salpingo-oophorectomy removes both fallopian tubes and ovaries to lower the chance of certain future cancers in people with particular inherited risks or other clinical reasons. It causes an immediate loss of ovarian hormone production and ends the possibility of becoming pregnant with those ovaries.

Menopause management after cancer addresses symptoms such as hot flushes, sleep disruption, vaginal discomfort, mood changes, and bone health concerns. It can be discussed before surgery, after surgery, or without surgery. The safe option depends on the cancer type, hormone sensitivity, treatments already received, age, fertility wishes, and other health conditions.

Ask your oncology team and a gynaecology or menopause specialist to coordinate the decision. Bring your pathology summary, treatment history, family cancer history, genetic test results if available, and a list of current symptoms. Discuss fertility preservation before any operation if future pregnancy matters to you.

Before choosing hormone or non-hormone treatment, ask how each option fits your cancer history. A plan may include symptom relief, sexual health support, bone protection, cardiovascular risk review, and follow-up for any inherited cancer risk.

Contact your clinical team promptly for new pelvic pain, persistent abdominal swelling, unexplained vaginal bleeding, a new breast change, or symptoms that begin suddenly after an operation. Seek urgent care for severe pain, heavy bleeding, fever, fainting, chest pain, or breathlessness. These symptoms need assessment regardless of whether surgery is planned.

Do I have a risk-based reason to consider removal of the ovaries and tubes? Would surgery change my menopause options? How will my cancer history affect hormone treatment? What fertility, sexual health, bone, and follow-up support should be arranged?